Recent developments in major pharmaceutical companies indicate a mixed outlook. Biogen's Leqembi shows promising sales, while Haleon and Novo Nordisk face setbacks due to weak U.S. demand and ...

Elon Musk’s brain implant company Neuralink Corp. is collaborating with researchers in California and Spain on a clinical ...

Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...